Amyloid β-Protein Fibrillogenesis

Cited by (1,000)

Items 301–400 of 1,000

1. Aggregation and structure of amyloid β-protein
   Kenjiro Ono, Takahiro Watanabe‐Nakayama · 2021 · Neurochemistry International
2. Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation
   Ghibom Bhak, Young‐Jun Choe, Seung-R. Paik · 2009 · BMB Reports
3. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches
   Parveen Salahuddin, Munazza Tamkeen Fatima, Ali S. Abdelhameed, Saima Nusrat, Rizwan Hasan Khan · 2016 · European Journal of Medicinal Chemistry
4. Transglutaminase Induces Protofibril-like Amyloid β-Protein Assemblies That Are Protease-resistant and Inhibit Long-term Potentiation
   Dean M. Hartley, Chaohui Zhao, Austin C. Speier, Gavitt Alida Woodard, Shaomin Li, Zongli Li, Thomas Walz · 2008 · Journal of Biological Chemistry
5. ApoE and Aβ1–42 Interactions: Effects of Isoform and Conformation on Structure and Function
   Manelli, Arlene M., Stine, W. Blaine, Van Eldik, Linda J., LaDu, Mary Jo · 2004 · Journal of Molecular Neuroscience
6. Native Chemical Ligation of Thioamide-Containing Peptides: Development and Application to the Synthesis of Labeled α-Synuclein for Misfolding Studies
   Solongo Batjargal, Yanxin J. Wang, Jacob M. Goldberg, Rebecca F. Wissner, E. James Petersson · 2012 · Journal of the American Chemical Society
7. The Metal Loading Ability of β-Amyloid N-Terminus: A Combined Potentiometric and Spectroscopic Study of Copper(II) Complexes with β-Amyloid(1−16), Its Short or Mutated Peptide Fragments, and Its Polyethylene Glycol (PEG)-ylated Analogue
   Chiara A. Damante, Katalin Ösz, Zoltán Nagy, Giuseppe Pappalardo, Giulia Grasso, Giuseppe Impellizzeri, Enrico Rizzarelli, Imre Sóvágó · 2008 · Inorganic Chemistry
8. A novelβ‐sheet breaker, RS‐0406, reverses amyloidβ‐induced cytotoxicity and impairment of long‐term potentiationin vitro
   Yasuhiro Nakagami, Satoko Nishimura, Takako Murasugi, Isao Kaneko, Masaki Meguro, Shinji Marumoto, Hiroshi Kogen, Kazuo Koyama, Tomiichiro Oda · 2002 · British Journal of Pharmacology
9. Amyloids: Friend or Foe?
   Neal D. Hammer, Xuan Wang, Bryan A. McGuffie, Matthew R. Chapman · 2008 · Journal of Alzheimer s Disease
10. Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: A novel mechanism of action
    Eugenio Barone, Giovanna Cenini, Fabio Di Domenico, Sarah K. Martin, Rukhsana Sultana A, Cesare Mancuso, Michael Paul Murphy, Elizabeth Head, David Allan Butterfield · 2010 · Pharmacological Research
11. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer’s Disease
    Kenjiro Ono, Mayumi Tsuji · 2020 · International Journal of Molecular Sciences
12. Transglutaminases and Transglutaminase‐Catalyzed Cross‐Links Colocalize with the Pathological Lesions in Alzheimer's Disease Brain
    Micha M.M. Wilhelmus, Sentini C.S. Grunberg, John G. J. M. Bol, Anne‐Marie van Dam, Jeroen J.M. Hoozemans, Annemieke J.M. Rozemüller, Benjamin Drukarch · 2008 · Brain Pathology
13. Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization
    Valérie Chesneau, Konstantinos Vekrellis, Marsha Rich Rosner, Dennis J. Selkoe · 2000 · Biochemical Journal
14. Amyloid fibrillation and cytotoxicity of insulin are inhibited by the amphiphilic surfactants
    Steven S.‐S. Wang, Kuan-Nan Liu, Tzu‐Chiang Han · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
15. Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment
    Rebecca B. Weinberg, Elliott Jay Mufson, Scott Counts · 2015 · Frontiers in Neuroscience
16. Evidence for Stepwise Formation of Amyloid Fibrils by the Mouse Prion Protein
    Shweta Jain, Jayant B. Udgaonkar · 2008 · Journal of Molecular Biology
17. Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3
    Rebeck, G. William, Kindy, Mark, LaDu, Mary Jo · 2002 · Journal of Alzheimer's Disease
18. pH-Dependent Amyloid and Protofibril Formation by the ABri Peptide of Familial British Dementia
    Rekha Srinivasan, Eric M. Jones, Keqian Liu, Jorge A. Ghiso, Roger E. Marchant, Michael G. Zagorski · 2003 · Journal of Molecular Biology
19. Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
    Butterfield, D. Allan, Boyd-Kimball, Debra · 2020 · Antioxidants
20. Development of Bifunctional Stilbene Derivatives for Targeting and Modulating Metal-Amyloid-β Species
    Joseph J. Braymer, Jung-Suk Choi, Alaina S. DeToma, Chen Wang, Kisoo Nam, Jeffrey W. Kampf, Ayyalusamy Ramamoorthy, Mi Hee Lim · 2011 · Inorganic Chemistry
21. Structure – Function Relationships of Pre-Fibrillar Protein Assemblies in Alzheimers Disease and Related Disorders
    Farid Rahimi, Akila Shanmugam, Gal Bitan · 2008 · Current Alzheimer Research
22. Pressure-dissociable reversible assembly of intrinsically denatured lysozyme is a precursor for amyloid fibrils
    T.N. Niraula, Takashi Konno, Hua Li, Hiroaki Yamada, Kazuyuki Akasaka, Hideki Tachibana · 2004 · Proceedings of the National Academy of Sciences
23. An Insight into the Pathway of the Amyloid Fibril Formation of Hen Egg White Lysozyme Obtained from a Small-angle X-ray and Neutron Scattering Study
    Yasushige Yonezawa, Shinpei Tanaka, Tomomi Kubota, Katsuzo Wakabayashi, Katsuhide Yutani, Satoru Fujiwara · 2002 · Journal of Molecular Biology
24. Dense‐core and diffuse Aβ plaques in TgCRND8 mice studied with synchrotron FTIR microspectroscopy
    Margaret Rak, Marc R. Del Bigio, Sabine Mai, David A. Westaway, Kathleen M. Gough · 2007 · Biopolymers
25. Shear flow promotes amyloid- fibrilization
    Dave E. Dunstan, Paul Hamilton‐Brown, Peter Asimakis, William A. Ducker, Joseph Bertolini · 2009 · Protein Engineering Design and Selection
26. Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone
    Puttur Santhoshkumar, K. Krishna Sharma · 2004 · Molecular and Cellular Biochemistry
27. Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin
    Vicki Betts, Malcolm A. Leissring, Georgia Dolios, Rong Wang, Dennis J. Selkoe, Dominic M. Walsh · 2008 · Neurobiology of Disease
28. Conformational changes of lysozyme refolding intermediates and implications for aggregation and renaturation
    Zhenyu Gu, Xiaonan Zhu, Shaowei Ni, Zhiguo G. Su, Hai‐Meng ZHOU · 2003 · The International Journal of Biochemistry & Cell Biology
29. Amino Acid Position-specific Contributions to Amyloid β-Protein Oligomerization
    Samir Kumar Maji, Rachel R. Ogorzalek Loo, Mohammed Inayathullah, Sean M. Spring, Sabrina S. Vollers, Margaret M. Condron, Gal Bitan, Joseph A. Loo, David B. Teplow · 2009 · Journal of Biological Chemistry
30. Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease
    David Allsop, Jennifer Mayes, Susan Moore, Atef A. Masad, Brian J. Tabner · 2008 · Biochemical Society Transactions
31. Transgenic C. elegans as a Model in Alzheimers Research
    Yanjue Wu, Yuan Luo · 2005 · Current Alzheimer Research
32. Reversible Mechanical Unzipping of Amyloid β-Fibrils
    Miklós Kellermayer, László Grama, Árpád Karsai, Attila Nagy, Amram Kahn, Zsolt Datki, Botond Penke · 2005 · Journal of Biological Chemistry
33. Cerebral clearance of human amyloid‐β peptide (1–40) across the blood–brain barrier is reduced by self‐aggregation and formation of low‐density lipoprotein receptor‐related protein‐1 ligand complexes
    Ito, Shingo, Ohtsuki, Sumio, Kamiie, Junichi, Nezu, Yasuko, Terasaki, Tetsuya · 2007 · Journal of Neurochemistry
34. CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease
    Michael R. Sierks, Gaurav Chatterjee, Claire E. McGraw, Srinath Kasturirangan, Philip Schulz, Shalini Prasad · 2011 · Integrative Biology
35. Secondary Structure and Interfacial Aggregation of Amyloid-β(1−40) on Sodium Dodecyl Sulfate Micelles
    Vijayaraghavan Rangachari, Dana Kim Reed, Brenda D. Moore, Terrone L. Rosenberry · 2006 · Biochemistry
36. Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid‐β variants in cells composing the cerebral vessel walls
    Silvia Fossati, Judy A. Cam, Jordana L. Meyerson, Emiliya Mezhericher, Ignacio Andres Romero, Pierre‐Olivier Couraud, Babette Barbash Weksler, Jorge A. Ghiso, Agueda A. Rostagno · 2009 · The FASEB Journal
37. The neuroprotective effects of Cerebrolysin? in a transgenic model of Alzheimer?s disease are associated with improved behavioral performance
    Edward M. Rockenstein, Anthony Adame, Michael Mante, Herbert Moessler, Manfred Windisch, Eliezer Masliah · 2003 · Journal of Neural Transmission
38. Role of glycine-33 and methionine-35 in Alzheimer’s amyloid β-peptide 1–42-associated oxidative stress and neurotoxicity
    Jarosław Kański, Sridhar Varadarajan, Marina V Aksenova, David Allan Butterfield · 2002 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
39. A Disulfide-Linked Amyloid-β Peptide Dimer Forms a Protofibril-like Oligomer through a Distinct Pathway from Amyloid Fibril Formation
    Takahiro J. YAMAGUCHI, Hisashi Yagi, Yuji Goto, Katsumi Matsuzaki, Masaru Hoshino · 2010 · Biochemistry
40. C-Terminal Turn Stability Determines Assembly Differences between Aβ40 and Aβ42
    Robin Roychaudhuri, Mingfeng Yang, Atul M. Deshpande, Gregory M. Cole, Sally Ann Frautschy, Aleksey Lomakin, George B. Benedek, David B. Teplow · 2012 · Journal of Molecular Biology
41. Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease
    Akihiko Nunomura, Toshio Tamaoki, Koich Tanaka, Nobutaka Motohashi, Masao Nakamura, Takaaki Hayashi, Haruyasu Yamaguchi, Shun Shimohama, Hyoung‐gon Lee, Xiongwei Zhu et al. · 2009 · Neurobiology of Disease
42. Sulfated Polysaccharides Promote the Assembly of Amyloid β1–42 Peptide into Stable Fibrils of Reduced Cytotoxicity
    Ramona Bravo, Muriel Arimon, Juan José Valle‐Delgado, Raquel Garcı́a, Núria Durany, Susanna Castel, Montserrat Cruz, Salvador Ventura, Xavier Fernàndez‐Busquets · 2008 · Journal of Biological Chemistry
43. Amino-Truncated β-Amyloid42 Peptides in Cerebrospinal Fluid and Prediction of Progression of Mild Cognitive Impairment
    Hugo Vanderstichele, Geert De Meyer, Niels Andreasen, Vesna Kostanjevečki, Anders Wallin, Annika Olsson, Kaj Blennow, Eugeen Vanmechelen · 2005 · Clinical Chemistry
44. Olive Oil Phenols as Promising Multi-targeting Agents Against Alzheimer’s Disease
    Stefania Rigacci · 2015 · Advances in experimental medicine and biology
45. Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
    Xiangyuan Meng, Qi Song, Zinan Liu, Xinpeng Liu, Yujie Wang, Jinyu Liu · 2024 · Frontiers in Aging Neuroscience
46. Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-β levels in female rats
    Anne S. Berry, Yasushi Tomidokoro, Jorge A. Ghiso, Janice E. Thornton · 2008 · Hormones and Behavior
47. Fibrillation of Human Insulin A and B Chains
    Dong-Pyo Hong, Atta Ahmad, Anthony L. Fink · 2006 · Biochemistry
48. Docosahexaenoic acid disrupts in vitro amyloid β1‐40 fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer’s disease model rats
    Michio Hashimoto, Hossain Md Shahdat, Shinji Yamashita, Masanori Katakura, Yoko Tanabe, Hironori Fujiwara, Shuji Gamoh, Teruo Miyazawa, Hiroyuki Arai, Toshio Shimada et al. · 2008 · Journal of Neurochemistry
49. Drugs targeting alzheimer’s disease: Some things old and some things new
    Michaelis, Mary L. · 2003 · The Journal of Pharmacology and Experimental Therapeutics
50. Characterizations of distinct amyloidogenic conformations of the Aβ (1–40) and (1–42) peptides
    Kwang Hun Lim, Hilary H. Collver, Yen T.H. Le, Partha S. Nagchowdhuri, John M. Kenney · 2006 · Biochemical and Biophysical Research Communications
51. AFM and STM study of β-amyloid aggregation on graphite
    Zhigang Wang, Chunqing Zhou, Chen Wang, Li‐Jun Wan, Xiaohong Fang, Chunli Bai · 2003 · Ultramicroscopy
52. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
    Yvonne S. Eisele, Charles J. Duyckaerts · 2015 · Acta Neuropathologica
53. Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition
    Erwin Cabrera, Paul M. Mathews, Emiliya Mezhericher, Thomas G. Beach, Jingjing Deng, Thomas A. Neubert, Agueda A. Rostagno, Jorge A. Ghiso · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
54. Cholesterol
    Robert L. Raffaı̈, Karl Heinrich Weisgraber · 2003 · Journal of Lipid Research
55. Isolated Amyloid-β(1–42) Protofibrils, But Not Isolated Fibrils, Are Robust Stimulators of Microglia
    Geeta S. Paranjape, Lisa K. Gouwens, David C. Osborn, Michael R. Nichols · 2012 · ACS Chemical Neuroscience
56. ADDLs & protofibrils —the missing links?
    William L. Klein · 2002 · Neurobiology of Aging
57. Unique Physicochemical Profile of β-Amyloid Peptide Variant Aβ1–40E22G Protofibrils: Conceivable Neuropathogen in Arctic Mutant Carriers
    Anna Päiviö, Jüri Jarvet, Astrid Gräslund, Lars Lannfelt, Anita Westlind‐Danielsson · 2004 · Journal of Molecular Biology
58. Fibrillogenesis and Cytotoxic Activity of the Amyloid-forming Apomyoglobin Mutant W7FW14F
    Ivana Sirangelo, Clorinda Malmo, Clara Iannuzzi, Antonio Mezzogiorno, Maria Rosaria Bianco, Michèle Papa, Gaetano Irace · 2004 · Journal of Biological Chemistry
59. Anti-Aggregating Effect of the Naturally Occurring Dipeptide Carnosine on Aβ1-42 Fibril Formation
    Alessandra Aloisi, Amilcare Barca, Alessandro Romano, Sara Guerrieri, Carlo Storelli, Rosaria Rinaldi, Tiziano Verri · 2013 · PLoS ONE
60. Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.
    Marina D. Kirkitadze, Anna Kowalska · 2005 · Acta Biochimica Polonica
61. Small non-fibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degeneration
    Brian M. Whalen, Dennis J. Selkoe, Dean M. Hartley · 2005 · Neurobiology of Disease
62. Membrane‐bound tetramer and trimer Aβ oligomeric species correlate with toxicity towards cultured neurons
    Metta K. Jana, Roberto Cappai, Chi L.L. Pham, Giuseppe D. Ciccotosto · 2015 · Journal of Neurochemistry
63. Protofibrils of amyloid β-protein inhibit specific K+ currents in neocortical cultures
    Chian P. Ye, Dennis J. Selkoe, Dean M. Hartley · 2003 · Neurobiology of Disease
64. Protective effect of donepezil against Aβ(1-40) neurotoxicity in rat septal neurons
    Manami Kimura, Shigeru Akasofu, Hiroo Ogura, Kohei Sawada · 2005 · Brain Research
65. Amyloid β-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-d-aspartate (NMDA) versus non-NMDA receptor/channel activation
    Chianping Ye, Dominic M. Walsh, Dennis J. Selkoe, Dean M. Hartley · 2004 · Neuroscience Letters
66. Methods for Analysis of Amyloid-β Aggregates
    Kim A. Bruggink, Mareike Müller, H. Bea Kuiperij, Marcel M. Verbeek · 2012 · Journal of Alzheimer s Disease
67. Formation of amyloid fibrils in vitro by human gammaD-crystallin and its isolated domains.
    Katerina Papanikolopoulou, Ishara Mills-Henry, Shannon Thol, Yongting Wang, Abby A.R. Gross, Daniel A. Kirschner, Sean M. Decatur, Jonathan King · 2008 · PubMed Central
68. Surface-Assisted Assembly of an Ionic-Complementary Peptide: Controllable Growth of Nanofibers
    Hong Yu Yang, Shan‐Yu Fung, Mark D. Pritzker, P Chen · 2007 · Journal of the American Chemical Society
69. Red cell perturbations by amyloid β-protein
    Jayakumar Rajadas, John W. Kusiak, Francis J. Chrest, Afolorunso Andrew Demehin, Murali Jayaraman, Robert P. Wersto, Enika Nagababu, Luke B. Ravi, Joseph Moses Rifkind · 2003 · Biochimica et Biophysica Acta (BBA) - General Subjects
70. Alternate Aggregation Pathways of the Alzheimer β-Amyloid Peptide
    T.H. Jackson Huang, Dun‐Sheng Yang, Paul E. Fraser, Avijit Chakrabartty · 2000 · Journal of Biological Chemistry
71. eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response
    Asad Jan, Brandon Jansonius, Alberto Delaidelli, Syam Prakash Somasekharan, Forum Bhanshali, Milène Vandal, Gian Luca Negri, Donald G. Moerman, Ian R. Mackenzie, Frédéric Calon et al. · 2016 · Acta Neuropathologica
72. The role of amyloids in Alzheimer's and Parkinson's diseases
    Parveen Salahuddin, Munazza Tamkeen Fatima, Vladimir Nikolaevich Uversky, Rizwan Hasan Khan, Zeyaul Islam, Mohammad Furkan · 2021 · International Journal of Biological Macromolecules
73. Charge states rather than propensity for β‐structure determine enhanced fibrillogenesis in wild‐type Alzheimer's β‐amyloid peptide compared to E22Q Dutch mutant
    Francesca Massi, Dmitri K. Klimov, Dave Thirumalai, John E. Straub · 2002 · Protein Science
74. Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils11Edited by J. Karn
    Omar M. A. El‐Agnaf, Sidhartha Nagala, Bhroma P. PATEL, Brian Austen · 2001 · Journal of Molecular Biology
75. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates
    Md Golam Sharoar, Arjun Thapa, Mohammad Shahnawaz, Vijay Sankar Ramasamy, Eun‐Rhan Woo, Song Seok Shin, Il‐Seon Park · 2012 · Journal of Biomedical Science
76. Investigations of the Molecular Mechanism of Metal-Induced Aβ (1−40) Amyloidogenesis
    Kwang Hun Lim, Yun Kyung Kim, Young‐Tae Chang · 2007 · Biochemistry
77. Apolipoprotein E3 (ApoE3) but Not ApoE4 Protects against Synaptic Loss through Increased Expression of Protein Kinase Cϵ
    Abhik Sen, Daniel L. Alkon, Thomas J. Nelson · 2012 · Journal of Biological Chemistry
78. Scanning Cysteine Mutagenesis Analysis of Aβ-(1-40) Amyloid Fibrils
    Shankaramma Shivaprasad, Ronald B. Wetzel · 2005 · Journal of Biological Chemistry
79. The molecular mechanisms of the anti-amyloid effects of phenols
    Hila Shoval, Dov A. Lichtenberg, Ehud Gazit · 2007 · Amyloid
80. Conformation of β2-Microglobulin Amyloid Fibrils Analyzed by Reduction of the Disulfide Bond
    Dong-Pyo Hong, Masayo Gozu, Kazuhiro Hasegawa, Hironobu Naiki, Yuji Goto · 2002 · Journal of Biological Chemistry
81. Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease
    Wenjin Xu, Shane M. Fitzgerald, Ralph A. Nixon, Efrat Levy, Donald A. Wilson · 2014 · Experimental Neurology
82. Olive Biophenols Reduces Alzheimer’s Pathology in SH-SY5Y Cells and APPswe Mice
    Syed Haris Omar, Christopher Scott, Adam S. Hamlin, Hassan K. Obied · 2018 · International Journal of Molecular Sciences
83. Monitoring Biomolecular Interactions by Time-Lapse Atomic Force Microscopy
    Martin Stolz, Daniel Stoffler, Ueli Aebi, Claire S. Goldsbury · 2000 · Journal of Structural Biology
84. Toxicity of non‐Aβ component of Alzheimer's disease amyloid, and N‐terminal fragments thereof, correlates to formation of β‐sheet structure and fibrils
    Angela M. Bodles, David J. S. Guthrie, Patrick Harriott, Pamela Campbell, G. Brent Irvine · 2000 · European Journal of Biochemistry
85. Low molecular weight oligomers of amyloid peptides display β-barrel conformations: A replica exchange molecular dynamics study in explicit solvent
    Alfonso De Simone, Philippe Derreumaux · 2010 · The Journal of Chemical Physics
86. Techniques for monitoring protein misfolding and aggregation in vitro and in living cells
    Simpson Gregoire, Jacob A. Irwin, Inchan Kwon · 2012 · Korean Journal of Chemical Engineering
87. Molecular Interactions of Alzheimer's Aβ Protofilaments with Lipid Membranes
    Florentina Tofoleanu, Nicolae‐Viorel Buchete · 2012 · Journal of Molecular Biology
88. Structures and Free-Energy Landscapes of the Wild Type and Mutants of the Aβ21–30 Peptide Are Determined by an Interplay between Intrapeptide Electrostatic and Hydrophobic Interactions
    Bogdan Tarus, John E. Straub, Dave Thirumalai · 2008 · Journal of Molecular Biology
89. Self-Association Process of a Peptide in Solution: From β-Sheet Filaments to Large Embedded Nanotubes
    Céline Valéry, Franck Artzner, Bruno Robert, T. Gulick, G. Keller, Cécile Grabielle-Madelmont, M.-L. Torres, Roland Cherif‐Cheikh, Maı̈té Paternostre · 2004 · Biophysical Journal
90. Generalization of the Prion Hypothesis to Other Neurodegenerative Diseases: An Imperfect Fit
    Will C. Guest, Judith M. Silverman, Edward Pokrishevsky, Megan A. O’Neill, Leslie I. Grad, Neil R. Cashman · 2011 · Journal of Toxicology and Environmental Health
91. Physiological Temperature Has a Crucial Role in Amyloid Beta in the Absence and Presence of Hydrophobic and Hydrophilic Nanoparticles
    Mahdi Ghavami, Meisam Rezaei, Mohammad Reza Ejtehadi, Mina Lotfi, Mohammad Ali Shokrgozar, Baharak Abd Emami, Jens Raush, Morteza Mahmoudi · 2012 · ACS Chemical Neuroscience
92. Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012)
    Federica Belluti, Angela Rampa, Silvia Gobbi, Alessandra Bisi · 2013 · Expert Opinion on Therapeutic Patents
93. Role of Apolipoprotein E in β-Amyloidogenesis
    Yukiko Hori, Tadafumi Hashimoto, Hidetoshi Nomoto, Bradley T. Hyman, Takeshi Iwatsubo · 2015 · Journal of Biological Chemistry
94. Unsaturated Fatty Acids Induce Cytotoxic Aggregate Formation of Amyotrophic Lateral Sclerosis-linked Superoxide Dismutase 1 Mutants
    Yeon‐Jeong Kim, Reiko Nakatomi, Takumi Akagi, Tsutomu Hashikawa, Ryōsuke Takahashi · 2005 · Journal of Biological Chemistry
95. Structural properties of fracture haematoma: current status and future clinical implications
    Xin Wang, Thor Friis, Vaida Glatt, Ross Crawford, Yin Xiao · 2016 · Journal of Tissue Engineering and Regenerative Medicine
96. Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer’s Disease Immunotherapy
    Jing Liu, Bin Yang, Jun Ke, Wenjia Li, Wen-Chen Suen · 2016 · Drugs & Aging
97. Mechanistic Understanding of the Interactions between Nano-Objects with Different Surface Properties and α-Synuclein
    Hossein Mohammad‐Beigi, A. Hosseini, Mohsen Adeli, Mohammad Reza Ejtehadi, Gunna Christiansen, Cagla Sahin, Zhaoxu Tu, Mahdi Tavakol, Arezou Dilmaghani‐Marand, Iraj Nabipour et al. · 2019 · ACS Nano
98. Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease
    Barnabas Wilson, K.M. Geetha · 2020 · Journal of Controlled Release
99. Conformational Dynamics of Amyloid β-Protein Assembly Probed Using Intrinsic Fluorescence
    Samir Kumar Maji, Jason J. Amsden, Kenneth J. Rothschild, Margaret M. Condron, David B. Teplow · 2005 · Biochemistry
100. High resolution scanning tunnelling microscopy of the β-amyloid protein (Aβ1–40) of Alzheimer’s disease suggests a novel mechanism of oligomer assembly
     Dušan Lošić, Lisandra L. Martin, Ádám Mechler, Marie‐Isabel Aguilar, David Henry Small · 2006 · Journal of Structural Biology